Regulatory Open Forum

 View Only
  • 1.  Establishment License

    This message was posted by a user wishing to remain anonymous
    Posted 23-Dec-2020 08:39
    This message was posted by a user wishing to remain anonymous

    Dear RAPS members,

    Should the DS and/ or DP manufacturer (CMO) look for Establishment license (EL) even if they manufacture clinical trial material and not commercial doses? Is there any applicable certification for such a facility?

    My understanding is EL is required only for commercial manufacturing.

    Thank you for sharing your experience.



  • 2.  RE: Establishment License

    Posted 23-Dec-2020 09:33
    Edited by Scott Bishop 23-Dec-2020 09:34

    Dear Anon,

    As it pertains to US FDA Establishment Registration, it depends on the specific situation.  I have included the link for your reference so that you may confirm the requirements for the specific situation.

    https://www.fda.gov/medical-devices/device-registration-and-listing/who-must-register-list-and-pay-fee



    ------------------------------
    Scott Bishop
    Houston TX
    United States
    ------------------------------



  • 3.  RE: Establishment License

    Posted 24-Dec-2020 06:59

    Dear Anon,

    With respect to Canada, see Section 2 (exemptions) of GUI-002 (Guidance on Drug Establishment Licenses). The guide notes that 'activities that comply with an authorised clinical trial do not require a DEL, except for clinical trials involving a marketed product used according to its Health Canada market authorization, sometimes referred to as a Phase IV clinical trial'. I hope this helps. 

    Kind regards,
    Felicia



    ------------------------------
    Felicia Mohammed RAC
    Regulatory Affairs Manager
    North York ON
    Canada
    ------------------------------



  • 4.  RE: Establishment License

    This message was posted by a user wishing to remain anonymous
    Posted 28-Dec-2020 09:56
    This message was posted by a user wishing to remain anonymous

    Scott and Felicia, thank you for your responses.